I agree that this site is using cookies. You can find further informations here.
X
Kantecki, Michal
38  results:
Search for persons X
?
1

Ceftaroline Fosamil as a Potential Treatment for Central Ne..:

Bradley, John S. ; Cattaneo, Dario ; Kantecki, Michal.
Infectious Diseases in Clinical Practice.  32 (2024)  4 - p. , 2024
Link: https://doi.org/10.1097/..
 
?
2

Real-World Use and Treatment Outcomes of Ceftaroline Fosami..:

Ferry, Tristan ; Gogos, Charalambos ; Soriano, Alex...
Infection and Drug Resistance.  17 (2024)  - p. 2773-2783 , 2024
Link: https://doi.org/10.2147/..
 
?
3

Ceftaroline fosamil treatment patterns and outcomes in adul..:

Soriano, Alex ; Bassetti, Matteo ; Gogos, Charalambos...
JAC-Antimicrobial Resistance.  6 (2024)  3 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
4

In vitro activity of aztreonam-avibactam and comparators ag..:

Rossolini, Gian Maria ; Arhin, Francis F. ; Kantecki, Michal
Journal of Global Antimicrobial Resistance.  36 (2024)  - p. 123-131 , 2024
Link: https://doi.org/10.1016/..
 
?
5

In vitro activity of aztreonam-avibactam and comparators ag..:

Gian Maria Rossolini ; Francis F. Arhin ; Michal Kantecki
http://www.sciencedirect.com/science/article/pii/S2213716523002278.  , 2024
Link: https://doi.org/10.1016/..
 
?
6

Evaluation of in vitro activity of ceftaroline against path..:

Utt, Eric ; Kantecki, Michal ; Cabezas-Camarero, Guillermo.
Journal of Global Antimicrobial Resistance.  33 (2023)  - p. 360-367 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Antimicrobial Activities of Aztreonam-Avibactam and Compara..:

Piérard, Denis ; Hermsen, Elizabeth D. ; Kantecki, Michal.
Antibiotics.  12 (2023)  11 - p. 1591 , 2023
Link: https://doi.org/10.3390/..
 
?
8

Evaluation of in vitro activity of ceftaroline against path..:

Eric Utt ; Michal Kantecki ; Guillermo Cabezas-Camarero.
http://www.sciencedirect.com/science/article/pii/S2213716523000784.  , 2023
Link: https://doi.org/10.1016/..
 
?
9

Ceftaroline Fosamil for the Empiric Treatment of Hospitaliz..:

Torres, Antoni ; Soriano, Alex ; Rivolo, Simone...
ClinicoEconomics and Outcomes Research.  14 (2022)  - p. 149-161 , 2022
Link: https://doi.org/10.2147/..
 
?
10

Treatment outcomes of secondary bacteraemia in patients tre..:

Dryden, Matthew ; Kantecki, Michal ; Yan, Jean Li...
Journal of Global Antimicrobial Resistance.  28 (2022)  - p. 108-114 , 2022
Link: https://doi.org/10.1016/..
 
?
11

In vitro activity of aztreonam/avibactam against isolates o..:

Rossolini, Gian Maria ; Stone, Gregory ; Kantecki, Michal.
Journal of Global Antimicrobial Resistance.  30 (2022)  - p. 214-221 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Treatment outcomes of secondary bacteraemia in patients tre..:

Matthew Dryden ; Michal Kantecki ; Jean Li Yan...
http://www.sciencedirect.com/science/article/pii/S2213716521002605.  , 2022
Link: https://doi.org/10.1016/..
 
?
13

Ceftaroline Fosamil for the Empiric Treatment of Hospitaliz..:

Torres, Antoni ; Soriano, Alex ; Rivolo, Simone...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CEOR.S329494.  , 2022
Link: https://www.dovepress.co..
 
?
14

Ceftaroline Fosamil for the Empiric Treatment of Hospitaliz..:

Torres, Antoni ; Soriano, Alex ; Rivolo, Simone...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939869/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Ceftaroline Fosamil for the Empiric Treatment of Hospitaliz..:

Torres Martí, Antoni ; Soriano Viladomiu, Alex ; Rivolo, Simone...
Reproducció del document publicat a: https://doi.org/10.2147/CEOR.S329494.  , 2022
Link: http://hdl.handle.net/24..
 
1-15